FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308679307> ?p ?o ?g. }

• W4308679307 endingPage "e750" @default.
• W4308679307 startingPage "e739" @default.
• W4308679307 abstract "COVID-19-related inflammation, endothelial dysfunction, and coagulopathy may increase the bleeding risk and lower the efficacy of revascularization treatments in patients with acute ischemic stroke (AIS). We aimed to evaluate the safety and outcomes of revascularization treatments in patients with AIS and COVID-19.This was a retrospective multicenter cohort study of consecutive patients with AIS receiving intravenous thrombolysis (IVT) and/or endovascular treatment (EVT) between March 2020 and June 2021 tested for severe acute respiratory syndrome coronavirus 2 infection. With a doubly robust model combining propensity score weighting and multivariate regression, we studied the association of COVID-19 with intracranial bleeding complications and clinical outcomes. Subgroup analyses were performed according to treatment groups (IVT-only and EVT).Of a total of 15,128 included patients from 105 centers, 853 (5.6%) were diagnosed with COVID-19; of those, 5,848 (38.7%) patients received IVT-only and 9,280 (61.3%) EVT (with or without IVT). Patients with COVID-19 had a higher rate of symptomatic intracerebral hemorrhage (SICH) (adjusted OR 1.53; 95% CI 1.16-2.01), symptomatic subarachnoid hemorrhage (SSAH) (OR 1.80; 95% CI 1.20-2.69), SICH and/or SSAH combined (OR 1.56; 95% CI 1.23-1.99), 24-hour mortality (OR 2.47; 95% CI 1.58-3.86), and 3-month mortality (OR 1.88; 95% CI 1.52-2.33). Patients with COVID-19 also had an unfavorable shift in the distribution of the modified Rankin score at 3 months (OR 1.42; 95% CI 1.26-1.60).Patients with AIS and COVID-19 showed higher rates of intracranial bleeding complications and worse clinical outcomes after revascularization treatments than contemporaneous non-COVID-19 patients receiving treatment. Current available data do not allow direct conclusions to be drawn on the effectiveness of revascularization treatments in patients with COVID-19 or to establish different treatment recommendations in this subgroup of patients with ischemic stroke. Our findings can be taken into consideration for treatment decisions, patient monitoring, and establishing prognosis.The study was registered under ClinicalTrials.gov identifier NCT04895462." @default.
• W4308679307 created "2022-11-14" @default.
• W4308679307 creator A5000209891 @default.
• W4308679307 creator A5000849433 @default.
• W4308679307 creator A5001019434 @default.
• W4308679307 creator A5001154406 @default.
• W4308679307 creator A5001225059 @default.
• W4308679307 creator A5001501497 @default.
• W4308679307 creator A5001542987 @default.
• W4308679307 creator A5001545910 @default.
• W4308679307 creator A5001559767 @default.
• W4308679307 creator A5001692371 @default.
• W4308679307 creator A5001760199 @default.
• W4308679307 creator A5001962415 @default.
• W4308679307 creator A5002123585 @default.
• W4308679307 creator A5002166472 @default.
• W4308679307 creator A5002659783 @default.
• W4308679307 creator A5002945373 @default.
• W4308679307 creator A5003195024 @default.
• W4308679307 creator A5003478524 @default.
• W4308679307 creator A5003834220 @default.
• W4308679307 creator A5003881417 @default.
• W4308679307 creator A5004117804 @default.
• W4308679307 creator A5004558231 @default.
• W4308679307 creator A5004908687 @default.
• W4308679307 creator A5005928956 @default.
• W4308679307 creator A5006107069 @default.
• W4308679307 creator A5006148616 @default.
• W4308679307 creator A5006546274 @default.
• W4308679307 creator A5007293238 @default.
• W4308679307 creator A5008048827 @default.
• W4308679307 creator A5008224042 @default.
• W4308679307 creator A5009320673 @default.
• W4308679307 creator A5010194490 @default.
• W4308679307 creator A5010987864 @default.
• W4308679307 creator A5010994268 @default.
• W4308679307 creator A5011506375 @default.
• W4308679307 creator A5011515853 @default.
• W4308679307 creator A5011652335 @default.
• W4308679307 creator A5011674120 @default.
• W4308679307 creator A5012204084 @default.
• W4308679307 creator A5012548193 @default.
• W4308679307 creator A5012842373 @default.
• W4308679307 creator A5012977856 @default.
• W4308679307 creator A5013211560 @default.
• W4308679307 creator A5013227649 @default.
• W4308679307 creator A5013643613 @default.
• W4308679307 creator A5013729461 @default.
• W4308679307 creator A5014564210 @default.
• W4308679307 creator A5014595744 @default.
• W4308679307 creator A5014677718 @default.
• W4308679307 creator A5014722039 @default.
• W4308679307 creator A5015086632 @default.
• W4308679307 creator A5015492668 @default.
• W4308679307 creator A5015773721 @default.
• W4308679307 creator A5016010299 @default.
• W4308679307 creator A5016765794 @default.
• W4308679307 creator A5017427835 @default.
• W4308679307 creator A5017783761 @default.
• W4308679307 creator A5017875370 @default.
• W4308679307 creator A5018010330 @default.
• W4308679307 creator A5018107308 @default.
• W4308679307 creator A5018231325 @default.
• W4308679307 creator A5018955063 @default.
• W4308679307 creator A5018998576 @default.
• W4308679307 creator A5019654607 @default.
• W4308679307 creator A5020093791 @default.
• W4308679307 creator A5020197789 @default.
• W4308679307 creator A5020723280 @default.
• W4308679307 creator A5020771276 @default.
• W4308679307 creator A5021000517 @default.
• W4308679307 creator A5021332109 @default.
• W4308679307 creator A5021542708 @default.
• W4308679307 creator A5022168164 @default.
• W4308679307 creator A5022751827 @default.
• W4308679307 creator A5022960844 @default.
• W4308679307 creator A5023473391 @default.
• W4308679307 creator A5023580073 @default.
• W4308679307 creator A5023593253 @default.
• W4308679307 creator A5024127963 @default.
• W4308679307 creator A5025293617 @default.
• W4308679307 creator A5025381085 @default.
• W4308679307 creator A5025574771 @default.
• W4308679307 creator A5025664148 @default.
• W4308679307 creator A5025727376 @default.
• W4308679307 creator A5026362870 @default.
• W4308679307 creator A5026682111 @default.
• W4308679307 creator A5026757659 @default.
• W4308679307 creator A5027004580 @default.
• W4308679307 creator A5027092557 @default.
• W4308679307 creator A5027588612 @default.
• W4308679307 creator A5027841465 @default.
• W4308679307 creator A5027896811 @default.
• W4308679307 creator A5029210202 @default.
• W4308679307 creator A5029381809 @default.
• W4308679307 creator A5029419565 @default.
• W4308679307 creator A5029541009 @default.
• W4308679307 creator A5029987464 @default.

• next